瘢痕疙瘩
成纤维细胞
癌症研究
平方毫米
化学
细胞外基质
信号转导
细胞生物学
细胞外
真核生物翻译延伸因子1α1
分子生物学
细胞因子
肌成纤维细胞
MDMX公司
细胞周期
细胞内
信使核糖核酸
转化生长因子
细胞生长
细胞培养
基因表达
细胞周期检查点
SMAD公司
细胞
作者
Ziqing Ye,Feng Liu,Huancheng Tang,Xiaoshuang Wang,Shuhua Liu,Qiongfang Ruan,Jun Hui Xu,Maolong Dong,Weiguo Xie,Siyu Zhang
摘要
Keloids are intricate fibroproliferative disorders characterized by sustained fibroblast activation, excessive deposition of extracellular matrix, and dysregulated wound-healing responses. This study explored the therapeutic effects and underlying mechanisms of Isoginkgetin (IGK) in keloid fibroblasts (KFbs) and a human keloid xenograft model. Our findings indicated that MDM2 expression was elevated in clinical keloid specimens, and IGK treatment inhibited KFbs proliferation and migration while inducing cell cycle arrest and apoptosis. Mechanistically, IGK downregulated MDM2 expression at the transcriptional level and was associated with the modulation of the MDM2/p53 signaling axis. LiP-MS and molecular docking analyses identified eukaryotic translation elongation factor 1 alpha 1 (EEF1A1) as a potential IGK-associated protein, suggesting that EEF1A1 may play a role in IGK-mediated regulation of MDM2 expression. Moreover, transcriptomic analysis of xenograft tissues combined with serum multicytokine profiling demonstrated that IGK treatment modulated inflammation-associated signatures, including those related to TNF signaling pathways, within the xenograft model. In vivo, administration of IGK resulted in a reduction in volume, collagen deposition, and α-SMA expression in established human keloid xenografts. Taken together, these findings indicate that IGK exerts anti-keloid effects by modulating the MDM2/p53 signaling axis and inflammation-associated pathways, underscoring its potential as a therapeutic candidate for keloid treatment.
科研通智能强力驱动
Strongly Powered by AbleSci AI